A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Teladoc Health, Inc.
TDOC
$1.5B
Mkt Cap
$8.77
+1.27%
Teladoc Health, Inc. (TDOC) has a 5-year average return on invested capital (ROIC) of -37.1%. This is below average and may indicate limited pricing power.
Teladoc Health, Inc. (TDOC) has a market capitalization of $1.6B. It is classified as a small-cap stock.
Teladoc Health, Inc. (TDOC) does not currently pay a regular dividend.
Teladoc Health, Inc. (TDOC) operates in the Services-Offices & Clinics Of Doctors Of Medicine industry, within the Healthcare sector.
Teladoc Health, Inc. (TDOC) reported annual revenue of $2.5 billion in its most recent fiscal year, based on SEC EDGAR filings.
Teladoc Health, Inc. (TDOC) has a net profit margin of -7.9%. The company is currently unprofitable.
Teladoc Health, Inc. (TDOC) generated $285 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Teladoc Health is the global leader in virtual care. More than 20 years ago, we were founded on a simple, yet revolutionary idea: that everyone should have access to the best healthcare, anywhere in the world on their terms. Our mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. Today, we are transforming virtual care into a catalyst for how better health happens around the world. We connect patients, care providers, healthcare platforms and partners to provide more complete and personalized care. Through our unique technology, breadth of services and depth of clinical expertise, we are delivering and orchestrating care in order to improve health outcomes and reduce healthcare costs around the world. We are equipping care teams to perform at their highest caliber, providing effective care and support that addresses and resolves comprehensive health needs— physical and mental, simple and complex, urgent and ongoing.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 2.5B | 2.5B | 2.6B | 2.6B | - | 2.0B |
| Net Income | -171M | -200M | -1.0B | -220M | -13.7B | -429M |
| EPS | $-0.96 | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 |
| Free Cash Flow | 280M | 285M | 283M | 339M | 173M | 185M |
| ROIC | -10.2% | -8.2% | -31.5% | -5.7% | -137.4% | -2.6% |
| Gross Margin | - | 69.5% | 70.8% | 70.8% | - | 68.0% |
| Debt/Equity | 0.75 | 0.75 | 1.06 | 0.68 | 0.69 | 0.08 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -204M | -263M | -1.0B | -249M | -13.7B | -266M |
| Operating Margin | -8.1% | -10.4% | -39.7% | -9.6% | - | -13.1% |
| ROE | -12.8% | -13.9% | -52.5% | -9.5% | -148.8% | -2.7% |
| Shares Outstanding | 180M | 176M | 171M | 164M | 161M | 157M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 44M | 77M | 123M | 233M | 418M | N/A | 1.1B | 2.0B | N/A | 2.6B | 2.6B | 2.5B | 2.5B |
| Gross Margin | 77.2% | 72.8% | 74.0% | 73.6% | 69.2% | N/A | 64.3% | 68.0% | N/A | 70.8% | 70.8% | 69.5% | N/A |
| R&D | 7.6M | 14M | 22M | 34M | 54M | 65M | 165M | 312M | 334M | 349M | 307M | 278M | 276M |
| SG&A | 18M | 43M | 49M | 80M | 117M | 164M | 507M | 438M | 450M | 465M | 435M | 432M | 421M |
| EBIT | -15M | -56M | -63M | -75M | -71M | -80M | -506M | -266M | -13.7B | -249M | -1.0B | -263M | -204M |
| Op. Margin | -34.8% | -72.1% | -50.9% | -32.3% | -17.0% | N/A | -46.3% | -13.1% | N/A | -9.6% | -39.7% | -10.4% | -8.1% |
| Net Income | -20M | -58M | -74M | -107M | -97M | -99M | -485M | -429M | -13.7B | -220M | -1.0B | -200M | -171M |
| Net Margin | -46.2% | -75.0% | -60.3% | -45.8% | -23.2% | N/A | -44.3% | -21.1% | N/A | -8.5% | -39.0% | -7.9% | -6.8% |
| Non-Recurring | 0 | 0 | 0 | 0 | 6.7M | 0 | 0 | 0 | 13.4B | 17M | 810M | 91M | 26M |
| Returns on Capital | |||||||||||||
| ROIC | -16.5% | -71.9% | -31.1% | -21.4% | -9.0% | -8.0% | -5.3% | -2.6% | -137.4% | -5.7% | -31.5% | -8.2% | -10.2% |
| ROE | 32.7% | -104.5% | -36.3% | -27.0% | -12.4% | -9.8% | -5.7% | -2.7% | -148.8% | -9.5% | -52.5% | -13.9% | -12.8% |
| ROA | -43.5% | -36.1% | -27.8% | -18.9% | -8.3% | -6.3% | -5.0% | -2.4% | -123.7% | -5.0% | -25.3% | -6.3% | -6.1% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | -11M | -47M | -52M | -34M | -4.9M | 30M | -54M | 194M | 189M | 350M | 294M | 294M | 288M |
| Free Cash Flow | -12M | -53M | -54M | -37M | -8.9M | 26M | -58M | 185M | 173M | 339M | 283M | 285M | 280M |
| Owner Earnings | -14M | -55M | -68M | -84M | -84M | -76M | -599M | -313M | -285M | 137M | 138M | 201M | -554M |
| CapEx | 1.1M | 6.3M | 2.1M | 2.6M | 4.0M | 3.5M | 4.0M | 8.5M | 16M | 11M | 11M | 8.9M | 7.8M |
| Maint. CapEx | 2.3M | 4.9M | 8.3M | 19M | 36M | 39M | 69M | 204M | 256M | 11M | 10M | 13M | 772M |
| Growth CapEx | 0 | 1.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 326K | 607K | 0 | 0 |
| D&A | 2.3M | 4.9M | 8.3M | 19M | 36M | 39M | 69M | 204M | 256M | 11M | 10M | 13M | 772M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | 11.8% | N/A | 4.4% | 8.7% | 3.3% | 3.7% | 3.0% | 2.7% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 368K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 533K | 3.1M | 7.7M | 31M | 44M | 67M | 476M | 303M | 218M | 202M | 146M | 80M | 70M |
| Debt Repayment | 0 | 6.3M | 17M | 226M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 551M | 551M |
| Balance Sheet | |||||||||||||
| Net Debt | -21M | -111M | -21M | 44M | -64M | -47M | 690M | 384M | 669M | 469M | 286M | 259M | 245M |
| Cash & Equiv. | 46M | 55M | 50M | 43M | 424M | 514M | 733M | 893M | 918M | 1.1B | 1.3B | 781M | 751M |
| Long-Term Debt | 25M | 25M | 42M | 167M | 415M | 440M | 1.4B | 1.2B | 1.5B | 1.5B | 991M | 995M | 996M |
| Debt/Equity | -0.38 | 0.15 | 0.19 | 0.30 | 0.41 | 0.46 | 0.09 | 0.08 | 0.69 | 0.68 | 1.06 | 0.75 | 0.75 |
| Interest Coverage | -30.3 | -25.4 | -24.2 | -4.3 | -2.7 | -2.7 | -8.4 | -3.3 | -622.2 | -11.2 | -42.9 | -13.3 | -13.3 |
| Equity | -68M | 179M | 231M | 559M | 1.0B | 1.0B | 15.9B | 16.0B | 2.3B | 2.3B | 1.5B | 1.4B | 1.3B |
| Total Assets | 92M | 230M | 304M | 824M | 1.5B | 1.6B | 17.8B | 17.7B | 4.3B | 4.4B | 3.5B | 2.9B | 2.8B |
| Total Liabilities | 159M | 51M | 73M | 49M | 94M | 92M | 1.9B | 1.7B | 407M | 2.1B | 2.0B | 1.5B | 1.5B |
| Intangibles | 7.5M | 15M | 25M | 160M | 247M | 225M | 2.0B | 1.9B | 1.8B | 1.7B | 1.4B | 1.3B | 1.2B |
| Retained Earnings | -72M | -131M | -205M | -312M | -409M | -508M | -993M | -1.4B | -15.0B | -15.2B | -16.2B | -16.4B | -16.5B |
| Working Capital | 44M | 134M | 62M | 116M | 470M | 498M | 727M | 894M | 916M | 1.1B | 722M | 714M | 727M |
| Current Assets | 54M | 152M | 83M | 156M | 533M | 588M | 1.1B | 1.2B | 1.3B | 1.5B | 1.7B | 1.1B | 1.1B |
| Current Liabilities | 10M | 18M | 21M | 40M | 62M | 90M | 333M | 331M | 400M | 421M | 942M | 405M | 405M |
| Per Share Data | |||||||||||||
| EPS | -5.13 | -1.46 | -0.88 | -0.97 | -0.74 | -0.69 | -5.36 | -2.73 | -84.60 | -1.34 | -5.87 | -1.14 | -0.96 |
| Owner EPS | -3.62 | -1.38 | -0.80 | -0.76 | -0.64 | -0.53 | -6.61 | -1.99 | -1.76 | 0.84 | 0.81 | 1.14 | -3.07 |
| Book Value | -17.20 | 4.48 | 2.72 | 5.05 | 7.67 | 7.08 | 175.49 | 102.16 | 14.29 | 14.14 | 8.74 | 7.89 | 7.41 |
| Cash Flow/Share | -2.89 | -1.18 | -0.61 | -0.31 | -0.04 | 0.21 | -0.59 | 1.24 | 1.17 | 2.13 | 1.72 | 1.68 | 3.33 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 3.9M | 39.9M | 84.8M | 110.7M | 132.1M | 143.3M | 90.5M | 157.1M | 161.5M | 164.5M | 170.6M | 175.7M | 180.4M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -9.1 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | 453.1 | N/A | 77.2 | 21.4 | 10.7 | 5.7 | 4.4 | 5.6 |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | 1.9 | 3.0 | 3.5 | 3.2 | 12.6 | 1.1 | 0.9 | 1.6 | 1.6 | 1.1 | 0.9 | 1.2 |
| Price/Sales | N/A | 5.9 | 5.2 | 6.8 | 8.7 | 18.0 | 14.6 | 12.8 | N/A | 1.5 | 0.8 | 0.6 | 0.6 |
| FCF Yield | N/A | -15.4% | -7.7% | -1.9% | -0.3% | 0.2% | -0.3% | 1.3% | 4.7% | 9.3% | 17.6% | 22.8% | 17.7% |
| Market Cap | N/A | 348M | 702M | 2.0B | 3.2B | 12.7B | 17.9B | 14.3B | 3.7B | 3.6B | 1.6B | 1.3B | 1.6B |
| Avg. Price | N/A | 22.82 | 15.12 | 28.85 | 54.74 | 65.12 | 176.13 | 165.41 | 44.92 | 23.42 | 12.06 | 8.25 | 8.77 |
| Year-End Price | N/A | 17.43 | 16.55 | 35.45 | 48.41 | 83.35 | 197.83 | 91.11 | 22.93 | 22.10 | 9.45 | 7.12 | 8.77 |
Teladoc Health, Inc. passes 4 of 9 quality checks, suggesting mixed fundamentals.
On a free-cash-flow basis, the stock trades at 5.5x vs a median of 10.7x. The company's 5-year average gross margin is 69.8%. At current prices, the estimated annualized return to fair value is +82.3%.
Teladoc Health, Inc. (TDOC) has a debt-to-equity ratio of 0.75. This indicates moderate leverage.
Teladoc Health, Inc. (TDOC) reported earnings per share (EPS) of $-1.14 in its most recent fiscal year.
Teladoc Health, Inc. (TDOC) has a return on equity (ROE) of -13.9%. A negative ROE may indicate losses or negative equity.
Teladoc Health, Inc. (TDOC) has a 5-year average gross margin of 69.8%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 13 years of financial data for Teladoc Health, Inc. (TDOC), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Teladoc Health, Inc. (TDOC) has a book value per share of $7.89, based on its most recent annual SEC filing.